Clinical Trial

STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)

Study acronym: STABLE-DCB
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate whether DCB angioplasty, compared to statin-based medical treatment alone, will lead to more reduction in plaque lipid burden as assessed by near infrared spectroscopy (NIRS) at 6-9 months following the index procedure.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-06-24; most recent amendment 2024-10-09.
Status change: Not Yet Recruiting → Recruiting 2022-12-11
Trial Details
NCT Number NCT05438121
Lead Sponsor Korea University Ansan Hospital
Collaborators: B. Braun Korea Co., Ltd.
Conditions Coronary Artery Disease, Atherosclerotic Plaque, De Novo Stenosis
Enrollment 65 participants
Start Date 2022-10-13
Primary Completion 2025-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-15